Patton Stephana Eilene Insider Trades

Insider Trading History

Track insider trading activity for Patton Stephana Eilene. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cutera
Cutera CUTR
Chief Legal Officer
Holding Value $7.48k 77,216 shares
Last Trade
Feb 13, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$262 623 shares
$0.42
$0.10
Cutera
Cutera CUTR
Chief Legal Officer
Holding Value $7.54k 77,839 shares
Last Trade
Nov 13, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$778 2,161 shares
$0.36
$0.10
Cutera
Cutera CUTR
Chief Legal Officer
Holding Value $14.3k 147,500 shares
Last Trade
Oct 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.4k 37,500 shares
$0.65
$0.10
Cutera
Cutera CUTR
Chief Legal Officer
Holding Value $0 0 shares
Last Trade
Jul 15, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$131k 85,000 shares
$1.54
$0.10
Cutera
Cutera CUTR
Chief Legal Officer
Holding Value $5.33k 55,000 shares
Last Trade
Jul 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$169k 110,000 shares
$1.54
$0.10
Cutera
Cutera CUTR
Chief Legal Officer
Holding Value $10.7k 110,000 shares
Last Trade
May 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$123k 55,000 shares
$2.23
$0.10
Cutera
Cutera CUTR
Chief Legal Officer
Holding Value $7.75k 80,000 shares
Last Trade
Mar 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.8k 25,000 shares
$2.11
$0.10
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
See Remarks
Holding Value $123k 71,250 shares
Last Trade
Mar 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.9M 83,125 shares
$299.70
$1.72
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
See Remarks
Holding Value $112k 65,000 shares
Last Trade
Mar 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.9M 65,000 shares
$168.00
$1.72
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
See Remarks
Holding Value $8.31k 4,820 shares
Last Trade
Mar 05, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$212k 820 shares
$258.00
$1.72
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
See Remarks
Holding Value $6.9k 4,000 shares
Last Trade
Apr 22, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$329k 1,000 shares
$329.10
$1.72
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
See Remarks
Holding Value $155k 90,000 shares
Last Trade
Mar 21, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$38.6M 90,000 shares
$429.30
$1.72
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel & Secretary
Holding Value $52.8k 43,995 shares
Last Trade
Dec 18, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$28.3k 27,500 shares
$1.03
$1.20
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel & Secretary
Holding Value $41.4k 34,485 shares
Last Trade
Dec 18, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.8k 9,510 shares
$1.03
$1.20
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel & Secretary
Holding Value $16.5k 13,750 shares
Last Trade
Dec 18, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$28.3k 27,500 shares
$1.03
$1.20
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel & Secretary
Holding Value $49.5k 41,250 shares
Last Trade
Oct 04, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$28.4k 13,750 shares
$2.06
$1.20
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel & Secretary
Holding Value $25.5k 21,250 shares
Last Trade
Oct 04, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$28.4k 13,750 shares
$2.06
$1.20
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel & Secretary
Holding Value $19.8k 16,495 shares
Last Trade
Oct 04, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$10.6k 4,755 shares
$2.22
$1.20
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel & Secretary
Holding Value $150k 125,000 shares
Last Trade
Mar 15, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$318k 125,000 shares
$2.54
$1.20
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel
Holding Value $9k 7,500 shares
Last Trade
Aug 21, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19.4k 7,500 shares
$2.58
$1.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up